Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* stroke investigators with age 65 to 80 years~* history of stroke between six months and 10 years~* Systolic pressure and Diastolic pressure were maintained under 160 mmHg and 110 mmHg~* INR \< 2.5, platelets counts 1-5 x 10\^5/μl~* Damaged area range between 0.5 cm to 6 cm by brain MRI~Exclusion Criteria:~* Pregnant women~* Investigators with AIDS, cancer, liver dysfunction~* Others can't fit into the trial evaluate by investigator

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- GXNPC1 (Type: EXPERIMENTAL): Three subjects will be to treatment (n=3) groups. The treatment group will receive brain transplants of autologous ADSCs. Treatment group will receive rehabilitation after the transplantation. Subjects will be assessed by magnetic resonance imaging (MRI) and four standardized stroke indices: National Institutes of Health Stroke Scale (NIHSS), European Stroke Scale (ESS), European Stroke Motor Subscale (EMS), Barthel Index, MMSE and Gait analyses at 1 month, 3 months, and 6 months after treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).